In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Inc.

www.pfizer.com

Latest From Pfizer Inc.

Keeping Track: US FDA Greenlights Two More Novel Drugs, But Smacks Down Golodirsen

The latest drug development news and highlights from our US FDA Performance Tracker.
US FDA Performance Tracker Approvals

Finance Watch: Five More Biopharmas Enter US Queue Even As IPO Returns Dip

Public Company Edition: SpringWorks has the biggest IPO ambitions of recent US filers. Also, Deciphera raises $400m after good data and Protalix seeks strategic alternatives.

Financing Strategy

Opioid Litigation Pushes American Pain Society Into Bankruptcy

Labeled by plaintiffs as a 'front group' for opioid makers, the organization was pulled into the multidistrict litigation in Ohio and filed for Chapter 7 bankruptcy in June. It ceased operations in July.

Legal Issues Policy

DREAMM-2 Put GSK’s BCMA Drug In Pole Position In Multiple Myeloma

The DREAMM-2 trial of the antibody-drug conjugate belantamab mafodotin in relapsed/refractory multiple myeloma patients has hit its primary endpoint, giving GSK a chance to file for approval before its BCMA rivals.

Clinical Trials Companies
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register